Changes in dermal fibroblasts from Abcc6-/- mice are present before and after the onset of ectopic tissue mineralization

Journal of Investigative Dermatology

Volumn 134, Issue 7, 2014, Pages 1855-1861

  Boraldi, Federica ^a   Bartolomeo, Angelica ^a   Li, Qiaoli ^b   Uitto, Jouni ^b   Quaglino, Daniela ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 6; OSTEOPONTIN; OXYGEN; PHOSPHODIESTERASE I; PYROPHOSPHATASE PHOSPHODIESTERASE 1; REACTIVE OXYGEN METABOLITE; TISSUE NONSPECIFIC ALKALINE PHOSPHATASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIFICATION; CELL ISOLATION; DISEASE COURSE; DOWN REGULATION; ECTOPIC TISSUE; FIBROBLAST; FIBROBLAST CULTURE; GENOTYPE; KNOCKOUT MOUSE; MINERALIZATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSEUDOXANTHOMA ELASTICUM; SPECTROPHOTOMETRY; UPREGULATION; WESTERN BLOTTING; WILD TYPE;

AGING; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CALCINOSIS; CELL PROLIFERATION; CELLS, CULTURED; DERMIS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ELASTIC TISSUE; EXTRACELLULAR MATRIX; FIBROBLASTS; MICE; MICE, KNOCKOUT; PSEUDOXANTHOMA ELASTICUM; REACTIVE OXYGEN SPECIES;

EID: 84902536765     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.88     Document Type: Article

References (33)

1. Bergen AA, Plomp AS, Schuurman EJ et al. (2000) Mutations in ABCC6 cause pseudoxanthoma elasticum. Nat Genet 25: 228-31
2. Boraldi F, Annovi G, Vermeer C et al. (2013) Matrix Gla protein and alkaline phosphatase are differently modulated in human dermal fibroblasts from PXE patients and controls. J Invest Dermatol 133: 946-54
3. Boraldi F, Annovi G, Tiozzo R et al. (2010) Comparison of ex vivo and in vitro human fibroblast ageing models. Mech Ageing Dev 131: 625-35
4. Boraldi F, Annovi G, Guerra D et al. (2009) Fibroblast protein profile analysis highlights the role of oxidative stress and vitamin K recycling in the pathogenesis of pseudoxanthoma elasticum. Proteomics Clin Appl 3: 1084-98
5. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-54
6. Byon CH, Javed A, Dai Q et al. (2008) Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J Biol Chem 283: 15319-27
7. Contri MB, Boraldi F, Taparelli F et al. (1996) Matrix proteins with high affinity for calcium ions are associated with mineralization within the elastic fibers of pseudoxanthoma elasticum dermis. Am J Pathol 148: 569-77
8. Derwall M, Malhotra R, Lai CS et al. (2012) Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis. Arterioscler Thromb Vasc Biol 32: 613-22
9. Garcia-Fernandez MI, Gheduzzi D, Boraldi F et al. (2008) Parameters of oxidative stress are present in the circulation of PXE patients. Biochim Biophys Acta 1782: 474-81
10. Gheduzzi D, Boraldi F, Annovi G et al. (2007) Matrix Gla protein is involved in elastic fiber calcification in the dermis of pseudoxanthoma elasticum patients. Lab Invest 87: 998-1008
11. Giachelli CM (2005) Inducers and inhibitors of biomineralization: lessons from pathological calcification. Orthod Craniofac Res 8: 229-31
12. Gorgels TG, Hu X, Scheffer GL et al. (2005) Disruption of Abcc6 in the mouse: novel insight in the pathogenesis of pseudoxanthoma elasticum. Hum Mol Genet 14: 1763-73
13. Jiang Q, Li Q, Uitto J (2007) Aberrant mineralization of connective tissues in a mouse model of pseudoxanthoma elasticum: systemic and local regulatory factors. J Invest Dermatol 127: 1392-402
14. Klement JF, Matsuzaki Y, Jiang QJ et al. (2005) Targeted ablation of the ABCC6 gene results in ectopic mineralization of connective tissues. Mol Cell Biol 25: 8299-310
15. Lawless C, Jurk D, Gillespie CS et al. (2012) A stochastic step model of replicative senescence explains ROS production rate in ageing cell populations. PLoS One 7:e32117
16. Le Saux O, Urban Z, Tschuch C et al. (2000) Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum. Nat Genet 25: 223-7
17. Le Saux O, Bunda S, VanWart CM et al. (2006) Serum factors from pseudoxanthoma elasticum patients alter elastic fiber formation in vitro. J Invest Dermatol 126: 1497-505
18. Li Q, Brodsky JL, Conlin LK et al. (2013) Mutations in the ABCC6 gene as a cause of generalized arterial calcification of infancy: genotypic overlap with pseudoxanthoma elasticum. J Invest Dermatol 134: 658-65
19. Li Q, Schumacher W, Jablonski D et al. (2012) Cutaneous features of pseudoxanthoma elasticum in a patient with generalized arterial calcification of infancy due to a homozygous missense mutation in the ENPP1 gene. Br J Dermatol 166: 1107-11
20. Li Q, Jiang Q, Pfendner E et al. (2008) Pseudoxanthoma elasticum: clinical phenotypes, molecular genetics and putative pathomechanisms. Exp Derm 18: 1-11
21. Li Q, Jiang Q, Schurgers LJ et al. (2007) Pseudoxanthoma elasticum: reduced gamma-glutamyl carboxylation of matrix gla protein in a mouse model (Abcc6-/-). Biochem Biophys Res Commun 364: 208-13
22. Li Q, Jiang Q, Uitto J (2008) Pseudoxanthoma elasticum: oxidative stress and antioxidant diet in a mouse model (Abcc6-/-). J Invest Dermatol 128: 1160-4
23. Mandal CC, Ganapathy S, Gorin Y et al. (2011) Reactive oxygen species derived from Nox4 mediate BMP2 gene transcription and osteoblast differentiation. Biochem J 433: 393-402
24. Pasquali-Ronchetti I, Garcia-Fernandez MI, Boraldi F et al. (2006) Oxidative stress in fibroblasts from patients with pseudoxanthoma elasticum: possible role in the pathogenesis of clinical manifestations. J Pathol 208: 54-61
25. Passi A, Albertini R, Baccarani Contri M et al. (1996) Proteoglycan alterations in skin fibroblast cultures from patients affected with pseudoxanthoma elasticum. Cell Biochem Funct 14: 111-20
26. Quaglino D, Boraldi F, Annovi G et al. (2011) The multifaceted complexity of genetic diseases: a lesson from pseudoxathoma elasticum. In: Ikehara K (ed), Advances in the study of genetic disorders. In Tech: Rijeka, Croazia, 289-318
27. Quaglino D, Sartor L, Garbisa S et al. (2005) Dermal fibroblasts from pseudoxanthoma elasticum patients have raised MMP-2 degradative potential. Biochim Biophys Acta 1741: 42-7
28. Quaglino D, Boraldi F, Barbieri D et al. (2000) Abnormal phenotype of in vitro dermal fibroblasts from patients with pseudoxanthoma elasticum (PXE). Biochim Biophys Acta 1501: 51-62
29. Rawadi G, Vayssi.re B, Dunn F et al. (2003) BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res 18: 1842-53
30. Ringpfeil F, Lebwohl MG, Christiano AM et al. (2000) Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter. Proc Natl Acad Sci USA 91: 6001-6
31. Ronchetti I, Boraldi F, Annovi G et al. (2013) Fibroblast involvement in soft connective tissue calcification. Front Genet 4:22
32. Scatena M, Liaw L, Giachelli CM (2007) Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 27: 2302-9
33. Speer MY, McKee MD, Guldberg RE et al. (2002) Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla proteindeficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. J Exp Med 196: 1047-55